The Challenge of Change - Managing Excipients Control
Colorcon
08-Jul-2004 - Much has been written on In-Pharmatechnologist.com about the impact on China of accession to the World Trade Organisation and the effects on the domestic pharmaceutical industry of the resulting need to comply with international intellectual property rules.
08-Jul-2004 - Germany's Boehringer Ingelheim has completed the validation process for its new biopharmaceutical production plant in Biberach with a positive inspection by the US Food and Drug Administration (FDA).
07-Jul-2004 - Sun Pharma of India has announced plans to buy an ailing cephalosporin bulk active company, Phlox Pharma, to gain access to an internationally approved generic active pharmaceutical ingredient.
07-Jul-2004 - Growing demand for natural colours, excipients and probiotic cultures lifted third quarter sales at Danish ingredients firm Chr Hansen.
07-Jul-2004 - Although Europe is a world leader in chemical production, holding 28 per cent of the world market, its proportion of global trade has dropped by 4 per cent over the past decade. The time has come to take action, according to two industry bodies.
06-Jul-2004 - UK business has attacked the government for handing out what it claims is a £4 billion annual bill as a result of 'sloppy' environmental laws, report Anthony Fletcher and Phil Taylor.
06-Jul-2004 - In the UK, a groundbreaking partnership between government and industry has led to the creation of a National Biomanufacturing Centre, designed to make it easier for fledgling biotechnology companies to get access to contract manufacturing for preclinical and clinical projects.
06-Jul-2004 - The market for pharmaceutical fine chemicals will remain static until 2005 and overcapacity will continue to be a problem, predicts Global Pharmaceutical Fine Chemicals - Industry and Market Analysis, a new report from Urch Publishing.
05-Jul-2004 - China has become the second largest producer of pharmaceutical ingredients in the world with an annual output of 800,000 tons, and tops the list in the production of five classes of pharmaceutical chemical.
05-Jul-2004 - Finnish chemicals group Kemira has agreed to sell off its fine chemicals business to a private equity firm, exiting from what it sees as a non-core sector, reports Phil Taylor.
05-Jul-2004 - The accusations levelled at GlaxoSmithKline and Forest Laboratories that negative trial results on their products have been buried has prompted the US industry to set out its own code of practice.
02-Jul-2004 - Charles River Laboratories has made a $1.5 billion (€1.2bn) bid to acquire Inveresk Research in a deal that will create a contract research powerhouse with nearly $1 billion in annual revenues, writes Phil Taylor.
01-Jul-2004 - Lanxess, the new company in which Germany's Bayer will combine almost all areas of its chemicals business and parts of its polymers activities, begins operating as an independent unit today.
01-Jul-2004 - New York Attorney General Elliot Spitzer has continued in his crusade to investigate pharmaceutical company practice by requesting information from Forest Laboratories which is accused of promoting its products for "off-label" usage.
01-Jul-2004 - Predictions that the generics industry will experience further consolidation - made at the annual meeting of the International Generic Pharmaceutical Alliance this week - have been swiftly followed by the news that Sandoz is buying AstraZeneca's generics subsidiary in Denmark.
30-Jun-2004 - Pricing pressure on the global market for citric acid has forced DSM of the Netherlands to lay off staff at its Citrique Belge unit, reports Phil Taylor.
30-Jun-2004 - UK companies producing hazardous waste - including the pharmaceutical industry - are facing a dramatic reduction in the number of landfill sites in the UK that will accept the material.
30-Jun-2004 - The market for generic drugs is going to expand from its present level of $35 billion (€29bn) to $80 billion in 2008, as cash-strapped healthcare payors turn increasingly to cheaper options.
28-Jun-2004 - ML Laboratories of the UK has entered into an agreement to supply an unnamed pharmaceutical company with its C200 metered dose inhaler, designed to deliver two drugs at the same time, for use in a new asthma product.
25-Jun-2004 - A strong indicator of the potential of a new type of drug to treat cancer - the Aurora kinase inhibitors - has come with Merck & Co's decision to invest up to $350 million (€288m) in a license for the lead compound in the class, reports Phil Taylor.
24-Jun-2004 - Swiss pharmaceuticals company Roche said it is investing 800 million Swiss francs (€530 million) to build two new manufacturing facilities in Europe.
24-Jun-2004 - The pharmaceutical industry must tackle the issue of pricing disparity between countries if it is to avoid having the matter taken out of its hands by government-mandated price cuts and parallel imports.
24-Jun-2004 - A group of research directors of leading pharmaceutical companies met this week to agree a framework for working together on research in a bid to make the European industry more competitive.
24-Jun-2004 - Foreign drugmakers are failing to win ground against their local counterparts in China, despite investing considerable sums in the country over the last few years.
23-Jun-2004 - Reforms that demand the public disclosure of industry payments to The National Institute of Health (NIH) employees are to be introduced to crackdown on the violation of existing rules that create a conflict of interest between the scientists' duties at NIH and their financial ties to the industry.